Table 3.
Criterion | Male (n = 615) | Female (n = 837) | Total (n = 1,452) | ||||||
---|---|---|---|---|---|---|---|---|---|
MetS− | MetS+ | % | MetS− | MetS+ | % | MetS− | MetS+ | % | |
China (2020) | 444 | 171 | 27.8 | 703 | 134 | 16.0* | 1,147 | 305 | 21.0 |
NCEP-ATPIII | 418 | 197 | 32.0 | 579 | 258 | 30.8 | 997 | 455 | 31.3& |
IDF | 433 | 182 | 29.6 | 589 | 248 | 29.6 | 1,022 | 430 | 29.6& |
*P < 0.05 compared with male patients; &P < 0.05 compared with China (2020).